Entering text into the input field will update the search result below

XBiotech nabs new patent in Canada

Sep. 20, 2019 8:33 AM ETXBiotech Inc. (XBIT) StockXBITBy: SA News Team
  • The Canadian Patent Office has granted XBiotech (NASDAQ:XBIT) a Patent Number 56003542-6CA covering the use of bermekimab in the treatment of inflammatory skin diseases.
  • XBiotech has conducted a number of clinical trials in dermatology using bermekimab, including studies in hidradenitis suppurativa, atopic dermatitis, and psoriasis vulgaris (plaque psoriasis).
  • The company has also published clinical findings for the treatment of psoriasis and acne.

Recommended For You

More Trending News

About XBIT Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
XBIT--
XBiotech Inc.